130 related articles for article (PubMed ID: 15536415)
1. Cysteinyl leukotriene receptor antagonist regulates vascular permeability by reducing vascular endothelial growth factor expression.
Lee KS; Kim SR; Park HS; Jin GY; Lee YC
J Allergy Clin Immunol; 2004 Nov; 114(5):1093-9. PubMed ID: 15536415
[TBL] [Abstract][Full Text] [Related]
2. Phosphoinositide 3-kinase-delta inhibitor reduces vascular permeability in a murine model of asthma.
Lee KS; Park SJ; Kim SR; Min KH; Jin SM; Puri KD; Lee YC
J Allergy Clin Immunol; 2006 Aug; 118(2):403-9. PubMed ID: 16890765
[TBL] [Abstract][Full Text] [Related]
3. An antioxidant modulates expression of receptor activator of NF-kappaB in asthma.
Lee KS; Park HS; Park SJ; Kim SR; Min KH; Jin SM; Li L; Lee YC
Exp Mol Med; 2006 Jun; 38(3):217-29. PubMed ID: 16819280
[TBL] [Abstract][Full Text] [Related]
4. A prodrug of cysteine, L-2-oxothiazolidine-4-carboxylic acid, regulates vascular permeability by reducing vascular endothelial growth factor expression in asthma.
Lee KS; Park HS; Park SJ; Kim SR; Min KH; Jin SM; Park KH; Kim UH; Kim CY; Lee YC
Mol Pharmacol; 2005 Nov; 68(5):1281-90. PubMed ID: 16103046
[TBL] [Abstract][Full Text] [Related]
5. Cysteinyl leukotriene upregulates IL-11 expression in allergic airway disease of mice.
Lee KS; Kim SR; Park HS; Park SJ; Min KH; Lee KY; Jin SM; Lee YC
J Allergy Clin Immunol; 2007 Jan; 119(1):141-9. PubMed ID: 17208595
[TBL] [Abstract][Full Text] [Related]
6. Phosphatase and tensin homolog deleted on chromosome 10 (PTEN) reduces vascular endothelial growth factor expression in allergen-induced airway inflammation.
Lee KS; Kim SR; Park SJ; Lee HK; Park HS; Min KH; Jin SM; Lee YC
Mol Pharmacol; 2006 Jun; 69(6):1829-39. PubMed ID: 16527906
[TBL] [Abstract][Full Text] [Related]
7. Role of cysteinyl leukotrienes in airway inflammation and responsiveness following RSV infection in BALB/c mice.
Fullmer JJ; Khan AM; Elidemir O; Chiappetta C; Stark JM; Colasurdo GN
Pediatr Allergy Immunol; 2005 Nov; 16(7):593-601. PubMed ID: 16238585
[TBL] [Abstract][Full Text] [Related]
8. Mast cells can mediate vascular permeability through regulation of the PI3K-HIF-1alpha-VEGF axis.
Lee KS; Kim SR; Park SJ; Min KH; Lee KY; Choe YH; Park SY; Chai OH; Zhang X; Song CH; Lee YC
Am J Respir Crit Care Med; 2008 Oct; 178(8):787-97. PubMed ID: 18669818
[TBL] [Abstract][Full Text] [Related]
9. Cysteinyl leukotrienes induce nuclear factor kappa b activation and RANTES production in a murine model of asthma.
Kawano T; Matsuse H; Kondo Y; Machida I; Saeki S; Tomari S; Mitsuta K; Obase Y; Fukushima C; Shimoda T; Kohno S
J Allergy Clin Immunol; 2003 Aug; 112(2):369-74. PubMed ID: 12897744
[TBL] [Abstract][Full Text] [Related]
10. Blockade of cysteinyl leukotriene-1 receptors suppresses airway remodelling in mice overexpressing GATA-3.
Kiwamoto T; Ishii Y; Morishima Y; Yoh K; Kikuchi N; Haraguchi N; Masuko H; Kawaguchi M; Nomura A; Sakamoto T; Takahashi S; Hizawa N
Clin Exp Allergy; 2011 Jan; 41(1):116-28. PubMed ID: 20636401
[TBL] [Abstract][Full Text] [Related]
11. Effect of a cysteinyl leukotriene receptor antagonist on experimental emphysema and asthma combined with emphysema.
Ikeda G; Miyahara N; Koga H; Fuchimoto Y; Waseda K; Kurimoto E; Taniguchi A; Tanimoto Y; Kataoka M; Tanimoto M; Kanehiro A
Am J Respir Cell Mol Biol; 2014 Jan; 50(1):18-29. PubMed ID: 23937413
[TBL] [Abstract][Full Text] [Related]
12. Involvement of LTD(4)in allergic pulmonary inflammation in mice: modulation by cysLT(1)antagonist MK-571.
Blain JF; Sirois P
Prostaglandins Leukot Essent Fatty Acids; 2000 Jun; 62(6):361-8. PubMed ID: 10913229
[TBL] [Abstract][Full Text] [Related]
13. Cysteinyl leukotriene receptor antagonist MK-571 alters bronchoalveolar lavage fluid proteome in a mouse asthma model.
Wong WS; Zhu H; Liao W
Eur J Pharmacol; 2007 Dec; 575(1-3):134-41. PubMed ID: 17689528
[TBL] [Abstract][Full Text] [Related]
14. Recombinant IGFBP-3 inhibits allergic lung inflammation, VEGF production, and vascular leak in a mouse model of asthma.
Kim SR; Lee KS; Lee KB; Lee YC
Allergy; 2012 Jul; 67(7):869-77. PubMed ID: 22563687
[TBL] [Abstract][Full Text] [Related]
15. Comparative study to elucidate the mechanism underlying the difference in airway hyperresponsiveness between two mouse strains.
Fukunaga J; Abe M; Murai A; Akitake Y; Hosokawa M; Takahashi M
Int Immunopharmacol; 2007 Dec; 7(14):1852-61. PubMed ID: 18039522
[TBL] [Abstract][Full Text] [Related]
16. Comparison study between the mechanisms of allergic asthma amelioration by a cysteinyl-leukotriene type 1 receptor antagonist montelukast and methylprednisolone.
Murai A; Abe M; Hayashi Y; Sakata N; Katsuragi T; Tanaka K
J Pharmacol Exp Ther; 2005 Feb; 312(2):432-40. PubMed ID: 15470084
[TBL] [Abstract][Full Text] [Related]
17. Montelukast inhibits inflammatory responses in small airways of the Guinea-pig.
Harrison S; Gatti R; Baraldo S; Oliani KL; Andre E; Trevisani M; Gazzieri D; Saetta M; Geppetti P
Pulm Pharmacol Ther; 2008; 21(2):317-23. PubMed ID: 17905619
[TBL] [Abstract][Full Text] [Related]
18. The effects of low dose leukotriene receptor antagonist therapy on airway remodeling and cysteinyl leukotriene expression in a mouse asthma model.
Muz MH; Deveci F; Bulut Y; Ilhan N; Yekeler H; Turgut T
Exp Mol Med; 2006 Apr; 38(2):109-18. PubMed ID: 16672764
[TBL] [Abstract][Full Text] [Related]
19. [Effects of leukotriene receptor antagonists on vascular endothelial growth factor and its receptors in a sensitized rat model].
Yang HS; Wang L; Yang W; Guan JT; Ma JY; Su Y
Zhonghua Jie He He Hu Xi Za Zhi; 2009 Mar; 32(3):177-81. PubMed ID: 19575935
[TBL] [Abstract][Full Text] [Related]
20. A selective cysteinyl leukotriene receptor 2 antagonist blocks myocardial ischemia/reperfusion injury and vascular permeability in mice.
Ni NC; Yan D; Ballantyne LL; Barajas-Espinosa A; St Amand T; Pratt DA; Funk CD
J Pharmacol Exp Ther; 2011 Dec; 339(3):768-78. PubMed ID: 21903747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
